Drinking green tea will make you live longer: Epigallocatechin gallate (EGCG), the major component of green tea, inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span via up regulation of its target gene, 26/March/2015, 10.41 am

MiRNA-based antimetastasis therapy: MiRNA-181 inhibits epithelial-mesenchymal transition and cancer cell proliferation via down regulation of GLUT3, 26/March/2015, 10.29 am
March 26, 2015
Natural product-based therapy for Stress-induced heart failure: Oleic acid (OA), the major component of Neem Oil, protects against stress-induced heart failure via up regulation of SNX13, 26/March/2015, 10.48 am
March 26, 2015
Show all

A recent study from the Institute of Healthy Ageing, Centre for Diabetes and Endocrinology, Department of Medicine, University College London, London WC1E 6JJ, UK shows that “Ribosomal protein S6 kinase 1 signaling regulates mammalian life span.” This study was published in the 2 October 2009 issue of the Journal “Science” (I.F: 31.477 )by Prof Dominic J. Withers, Dr. Selman C and others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMDreports that: Natural product-based Life-span extension therapy: Epigallocatechin gallate (EGCG), the major component of green tea,  inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span via up regulation of its target gene. 

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Drinking green tea will make you live longer: Epigallocatechin gallate (EGCG), the major component of green tea, inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span via up regulation of its target gene, 26/March/2015, 10.41 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Significance: This study suggests that tumor suppressor Epigallocatechin gallate (EGCG), by increasing the expression of its target gene, it may decrease the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase). Thereby, it may promote (1) resistance to bone, immune, and motor dysfunction; and (2) insulin sensitivity.  Thus, pharmacological formulations encompassing Epigallocatechin gallate (EGCG) or its analogues may be used to extend the life span of an individual.

Undisclosed information: How Epigallocatechin gallate (EGCG) decreases the expression of p70S6 Kinase

* Research cooperation

Comments are closed.